EPISODE · Jun 1, 2026 · 24 MIN
The Manual Override: Why Breathwork Outperforms Pharmaceuticals for Anxiety
from Breath Lab Podcast · host Breath Lab
Recent peer-reviewed data from 2026 reveals that structured breathwork, specifically alternate nostril breathing, can achieve a Cohen’s d effect size of 1.44—vastly outperforming the 0.3 to 0.5 typically reported in SSRI antidepressant trials. By slowing respiration to exactly six breaths per minute (0.1 Hertz), practitioners trigger a state of cardiovascular resonance where heart rate and blood pressure waves phase-lock, significantly increasing heart rate variability. Modern neuroimaging confirms that this practice physically shifts blood flow away from the hyper-vigilant insula and toward the amygdala, allowing the brain to process stored emotional trauma while the body signals profound physical safety. While the autonomic shift begins in a single fifteen-minute session, achieving a permanent baseline shift requires navigating a 66-day habit-formation window to overcome the cognitive friction of the practice and lock in the neurological benefits.#breathwork #neuroscience #anulomaviloma #anxietyrelief #HRV #0.1Hertz #mentalhealth #vagusnerveAnuloma Viloma Timer is free on the App Store. No subscription necessary. Apple Watch standalone, customisable ratios, beautiful experience. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit breathlab.substack.com
Embed this episode
NOW PLAYING
The Manual Override: Why Breathwork Outperforms Pharmaceuticals for Anxiety
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.